作者：
Flannick,J. [1]
;
Beer,N.L. [2]
;
Bick,A.G. [3]
;
Agarwala,V. [4]
;
Molnes,J. [5]
;
Gupta,N. [6]
;
Burtt,N.P. [7]
;
Florez,J.C. [8]
;
Meigs,J.B. [9]
;
Taylor,H. [10]
;
Lyssenko,V. [11]
;
Irgens,H. [12]
;
Fox,E. [13]
;
Burslem,F. ;
Johansson,S. ;
Brosnan,M.J. ;
Trimmer,J.K. ;
Newton-Cheh,C. ;
Tuomi,T. ;
Molven,A. ;
Wilson,J.G. ;
O'Donnell,C.J. ;
Kathiresan,S. ;
Hirschhorn,J.N. ;
Nj?lstad,P.R. ;
Rolph,T. ;
Seidman,J.G. ;
Gabriel,S. ;
Cox,D.R. ;
Seidman,C.E. ;
Groop,L. ;
Altshuler,D.
作者单位：
National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA, United States
[1]
Applied Quantitative Genotherapeutics, Pfizer Inc., South San Francisco, CA, United States
[2]
Cardiovascular and Metabolic Diseases Practice, Prescient Life Sciences, London, United Kingdom
[3]
Department of Medicine, University of Mississippi Medical Center, Jackson, MS, United States
[4]
Program in Medical and Population Genetics, Broad Institute of Harvard and Massachusetts Institute
[5]
Department of Clinical Sciences, Diabetes and Endocrinology, Clinical Research Centre, Lund
[6]
Department of Genetics, Harvard Medical School, Boston, MA, United States, Division of
[7]
Department of General Practice and Primary Health Care, University of Helsinki, Helsinki, Finland
[8]
Department of Genetics, Harvard Medical School, Boston, MA, United States
[9]
KG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen
[10]
Department of Medicine, Harvard Medical School, Boston, MA, United States, General Medicine
[11]
Cardiovascular and Metabolic Diseases Research Unit, Pfizer Inc., Cambridge, MA, United States
[12]
Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS
[13]
发布时间
2014-07-08
换一批
